300534.SZ
陇神戎发
SZSE · Healthcare · C 制造业 · CN
CNY 16.70
−8.99%Year over year
Reported trailing growth
- Revenue
- -20.6%
- EBITDA
- —
- EBIT
- -18.8%
- EPS
- +129.3%
- Free cash flow
- +13.8%
- Operating cash flow
- -40.5%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +3.5%
- EBITDA
- +17.0%
- EBIT
- +16.5%
- Net income
- +4.3%
- EPS
- +4.2%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026